Stock CTMX CYTOMX THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart CytomX Therapeutics, Inc.

Equities

CTMX

US23284F1057

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-08 pm EDT 		After market 06:36:19 pm
4.19 USD +2.95% Intraday chart for CytomX Therapeutics, Inc. 2.535 -39.50%
May. 08 Earnings Flash (CTMX) CYTOMX THERAPEUTICS Reports Q1 Revenue $41.5M MT
May. 07 CytomX Therapeutics, Inc. Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with Keytruda® (pembrolizumab) CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CYTOMX THERAPEUTICS, INC. Stock CytomX Therapeutics, Inc.
 276M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 106B
ARGENX SE Stock argenx SE
 23.47B -
BIONTECH SE Stock BioNTech SE
 21.9B -
GENMAB A/S Stock Genmab A/S
 18.77B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
 17.85B
  1. Stock Market
  2. Equities
  3. CTMX Stock
  4. Charts CytomX Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW